Hesi Chronic Kidney Disease Case Study

HESI Chronic Kidney Disease Case Study: A Comprehensive Educational Guide

Chronic kidney disease (CKD) remains a leading cause of morbidity worldwide, and nursing students preparing for the HESI exam frequently encounter case studies that test their ability to integrate pathophysiology, assessment, and evidence‑based interventions. This article walks through a typical HESI chronic kidney disease case study, breaking down each component so learners can grasp the clinical reasoning required to succeed on the exam and in real‑world practice Surprisingly effective..

Introduction

The HESI (Health Education Systems, Inc.So naturally, ) exam evaluates nursing competence across core content areas, including renal health. A chronic kidney disease case study on the HESI exam usually presents a patient with progressive loss of kidney function, laboratory abnormalities, and comorbid conditions such as hypertension or diabetes. Consider this: by analyzing the scenario, students must identify priority nursing diagnoses, plan appropriate interventions, and evaluate outcomes. Understanding the underlying pathophysiology and standard nursing care for CKD is essential for answering HESI‑style questions accurately.

Case Presentation

Patient Profile

• Name: Mr. James L., 58‑year‑old African American male
• Chief Complaint: “I’ve been feeling more tired lately and notice swelling in my ankles.”
• History of Present Illness: Over the past 6 months, Mr. L. reports increasing fatigue, decreased appetite, and nocturia (3–4 episodes per night). He notes 2 kg weight gain and pitting edema bilaterally up to the mid‑calf. He denies chest pain or shortness of breath at rest.
• Past Medical History: Type 2 diabetes mellitus diagnosed 12 years ago (HbA1c 8.2 %), hypertension for 10 years (BP 150/95 mm Hg on two antihypertensives), hyperlipidemia. No prior renal disease.
• Medications: Metformin 500 mg BID, lisinopril 20 mg daily, atorvastatin 20 mg nightly, aspirin 81 mg daily.
• Allergies: NKDA
• Social History: Former smoker (10 pack‑years, quit 5 years ago), consumes alcohol occasionally, retired mechanic, lives with spouse.
• Family History: Father died of myocardial infarction at 62; mother alive with hypertension.
• Physical Exam:
  • Vital signs: BP 158/92 mm Hg, HR 78 bpm, RR 18, SpO₂ 98% on room air, Temp 36.8 °C.
  • General: Alert, oriented x3, mild fatigue noted.
  • Cardiovascular: Regular rate and rhythm, no murmurs.
  • Respiratory: Clear to auscultation bilaterally.
  • Abdomen: Soft, non‑tender, no organomegaly.
  • Extremities: 2+ pitting edema bilateral ankles, warm, pulses 2+ dorsalis pedis.
  • Skin: No rashes, good turgor.
• Laboratory Results:
  • Serum creatinine: 2.8 mg/dL (baseline 1.0 mg/dL)
  • BUN: 48 mg/dL
  • eGFR (CKD‑EPI): 22 mL/min/1.73 m²
  • Serum potassium: 5.6 mmol/L (mild hyperkalemia)
  • Serum bicarbonate: 20 mmol/L (mild metabolic acidosis)
  • Urinalysis: Protein 3+, hematuria trace, specific gravity 1.015
  • Urine albumin‑to‑creatinine ratio: 350 mg/g (macroalbuminuria)
  • HbA1c: 8.5 %
  • Lipid panel: LDL 130 mg/dL, HDL 38 mg/dL, triglycerides 210 mg/dL

Interpretation: The laboratory values indicate stage 4 CKD (eGFR 15‑29 mL/min/1.73 m²) with significant proteinuria, uncontrolled hypertension, and suboptimal glycemic control.

Pathophysiology of Chronic Kidney Disease

Chronic kidney disease results from irreversible loss of nephrons, leading to a progressive decline in glomerular filtration rate (GFR). And in patients with diabetes and hypertension—like Mr. L.

1. Hyperfiltration Injury: Early diabetes causes increased glomerular pressure and flow, damaging the glomerular basement membrane.
2. Glomerulosclerosis: Persistent hypertension transmits elevated systemic pressure to the glomeruli, causing sclerosis and loss of filtration surface area.
3. Tubulointerstitial Fibrosis: Proteinuria triggers inflammatory cytokines that promote fibroblast activation and extracellular matrix deposition, further reducing nephron mass.
4. Renin‑Angiotensin‑Aldosterone System (RAAS) Activation: Reduced renal perfusion stimulates renin release, worsening hypertension and fibrosis.
5. Uremic Toxin Accumulation: As GFR falls, waste products (urea, creatinine, indoles) accumulate, contributing to fatigue, nausea, and platelet dysfunction.

Understanding these processes helps nursing students prioritize interventions that target blood pressure control, glycemic management, and proteinuria reduction.

Nursing Assessment

A systematic assessment guides the identification of nursing diagnoses and the planning of care. Key areas include:

• Fluid Status: Monitor weight daily, assess for edema, jugular venous distension, and pulmonary crackles.
• Electrolytes: Watch potassium closely due to risk of life‑threatening hyperkalemia; monitor sodium, bicarbonate, and calcium.
• Acid‑Base Balance: Evaluate for metabolic acidosis (low bicarbonate) that may require supplementation.
• Nutritional Status: Assess appetite, dietary protein intake, and signs of malnutrition (e.g., muscle wasting). - Skin Integrity: Inspect for edema‑related skin breakdown, especially in dependent areas.
• Neurologic: Monitor for lethargy, confusion, or asterixis as signs of uremic encephalopathy. - Psychosocial: Screen for depression, anxiety, and adherence challenges related to complex medication regimens.

Priority Nursing Diagnoses (based on NANDA‑I):

1. Excess Fluid Volume related to decreased renal excretion and sodium retention.
2. Risk for Electrolyte Imbalance (hyperkalemia) related to reduced glomerular filtration.
3. Activity Intolerance related to fatigue and anemia of chronic disease.
4. Imbalanced Nutrition: Less Than Body Requirements related to dietary restrictions and anorexia.

Nursing Interventions and Outcomes

Based on the identified diagnoses, nursing interventions must be proactive, interdisciplinary, and individualized.

For Excess Fluid Volume:

• Implement strict daily weight monitoring and intake/output (I&O) recording.
• Administer prescribed diuretics (e.g., furosemide) and monitor response.
• Elevate edematous extremities and enforce sodium restriction (typically <2,300 mg/day).
• Goal: Patient will maintain euvolemia, evidenced by stable weight, absence of edema, and clear lung sounds.

For Risk for Electrolyte Imbalance:

• Monitor serum potassium, sodium, and bicarbonate at least weekly, or more frequently if unstable.
• Educate patient on high-potassium foods to avoid (e.g., bananas, oranges, potatoes) and the importance of adhering to dietary restrictions.
• Prepare for potential emergency interventions (e.g., calcium gluconate, insulin/glucose, sodium polystyrene) if hyperkalemia is suspected.
• Goal: Electrolytes remain within target range; patient verbalizes understanding of dietary modifications.

For Activity Intolerance:

• Collaborate with the patient to schedule rest periods and prioritize activities.
• Assess for anemia (check hemoglobin/hematocrit) and coordinate with the provider regarding potential erythropoietin-stimulating agent (ESA) therapy or iron supplementation.
• Encourage gentle, regular activity as tolerated (e.g., short walks) to maintain conditioning.
• Goal: Patient reports improved energy and completes activities of daily living (ADLs) with minimal fatigue.

For Imbalanced Nutrition:

• Consult a renal dietitian to develop a meal plan that limits protein (to reduce uremic toxin generation), sodium, phosphorus, and potassium while ensuring adequate caloric intake.
• Offer small, frequent meals and appetite stimulants if appropriate.
• Monitor for signs of protein-energy wasting (e.g., decreased muscle mass, low serum albumin).
• Goal: Patient maintains or gradually gains weight and meets ≥75% of caloric/protein goals as prescribed.

Cross-Cutting Interventions:

• Medication Management: Ensure understanding of RAAS inhibitors (e.g., lisinopril), which reduce proteinuria and hypertension but require monitoring for cough or hyperkalemia.
• Psychosocial Support: help with access to counseling or support groups; assess for treatment fatigue.
• Education: Teach the “3 Ds”—Diet, Drugs (adherence), and Doctor visits—to slow CKD progression. point out smoking cessation.
• Care Coordination: Work with the nephrologist, dietitian, social worker, and pharmacist to create a cohesive care plan, including advance care planning discussions as CKD advances.

Conclusion

The management of chronic kidney disease in patients like Mr. Because of that, demands a comprehensive nursing approach that directly addresses the intertwined pathophysiological mechanisms of hyperfiltration injury, fibrosis, and toxin accumulation. Through meticulous assessment, precise diagnosis, and targeted interventions—centering on fluid and electrolyte balance, nutritional optimization, activity pacing, and solid patient education—nurses play a critical role in interrupting the cycle of renal decline. But l. By controlling hypertension and diabetes, reducing proteinuria, and supporting holistic well-being, nursing care not only mitigates acute complications but also fundamentally slows the progression toward end-stage renal disease, empowering patients to maintain the highest possible quality of life for as long as possible. The ultimate goal is to transform a trajectory of inevitable loss into one of managed stability and preserved dignity.